SFRP1 and central nervous system cancer: The aforesaid findings disclose that MTE can inhibit the growth of glioma in situ in nude mice via the lncMEG3/miR‐542‐3p‐mediated upregulation of SFRP1 and suppression of the Wnt/β‐catenin pathway.